EXHIBIT 10.11 DEVELOPMENT AGREEMENTDevelopment Agreement • September 25th, 1998 • Anthra Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 25th, 1998 Company Industry Jurisdiction
1 2 (a) "Development Agreement" shall mean the undated form of Development and Commercialization Agreement among Leiras, Berlex and Anthra identified as 4429/18/JKK, annexed hereto as Exhibit A and initialed by the parties for purposes of further...Option Agreement • September 25th, 1998 • Anthra Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 25th, 1998 Company Industry Jurisdiction
ANDAnthra Pharmaceuticals Inc • September 25th, 1998 • In vitro & in vivo diagnostic substances • New York
Company FiledSeptember 25th, 1998 Industry Jurisdiction
Form ofUnit and Warrant Agreement • September 25th, 1998 • Anthra Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 25th, 1998 Company Industry Jurisdiction
ADOPTION AGREEMENT FOR THE ABR BENEFITS SERVICES, INC. REGIONAL PROTOTYPE STANDARDIZED CASH OR DEFERRED PROFIT SHARING PLAN AND TRUST (WITH PAIRING PROVISIONS) ------------------------------------------------------------- 2 ADOPTION AGREEMENT FOR THE...Anthra Pharmaceuticals Inc • September 25th, 1998 • In vitro & in vivo diagnostic substances
Company FiledSeptember 25th, 1998 Industry
JANSSEN-MEYERS ASSOCIATES, L.P. 17 State Street New York, NY 10004Anthra Pharmaceuticals Inc • September 25th, 1998 • In vitro & in vivo diagnostic substances • New York
Company FiledSeptember 25th, 1998 Industry Jurisdiction
2,000,000 Units, each Unit Consisting of One (1) Share of Common Stock and One (1) Redeemable Class A Common Stock Purchase Warrant ofAnthra Pharmaceuticals Inc • September 25th, 1998 • In vitro & in vivo diagnostic substances • New York
Company FiledSeptember 25th, 1998 Industry Jurisdiction